Arena Pharma (ARNA) says FDA accepts resubmission of Lorcaserin NDA; sets PDUFA date as June 27th, 2012
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharma (Nasdaq: ARNA) says FDA accepts resubmission of Lorcaserin NDA; sets PDUFA date as June 27th, 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- loanDepot receives NYSE non-compliance notice over stock price
- Home Depot expands executive roles, grants $500K in restricted stock
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
